A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent

BMC Public Health

Volumn 7, Issue , 2007, Pages

  Brabin, Loretta ^a   Roberts, Stephen A ^b   Kitchener, Henry C ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CHILD BEHAVIOR; CHILD PARENT RELATION; CULTURAL ANTHROPOLOGY; DECISION MAKING; FEMALE; HEALTH CENTER; HEALTH SURVEY; HUMAN; INFORMED CONSENT; MALE; MEDICAL ETHICS; PARENTAL ATTITUDE; PARENTAL CONSENT; POPULATION RESEARCH; PROFESSIONAL SECRECY; QUALITATIVE ANALYSIS; SEXUAL HEALTH; VACCINATION; VIRUS INFECTION; WART VIRUS; ADOLESCENT; ATTITUDE TO HEALTH; CHILD; CROSS-SECTIONAL STUDY; QUESTIONNAIRE; UNITED KINGDOM; UTERINE CERVICAL NEOPLASMS;

ADOLESCENT; ATTITUDE TO HEALTH; CHILD; CROSS-SECTIONAL STUDIES; DECISION MAKING; FEMALE; GREAT BRITAIN; HUMANS; PAPILLOMAVIRUS VACCINES; PARENTAL CONSENT; QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS;

EID: 33847236172     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-7-20     Document Type: Article

References (36)

1. Prophylactic human papillomavirus (types 6,11,16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. LL Villa RR Costa CA Petta R Andrade K Ault A Giuliano C Wheeler L Koutsky C Malm M Lehtinen, Lancet Oncol 2005 6 271 8 10.1016/S1470-2045(05)70101-7 15863374
2. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management. JA Brinkman AS Caffrey LI Muderspach LD Roman WM Kast, Eur J Gynaecol Oncol 2005 XXVI 129 142
3. HPV vaccine introduction in industrialized countries. TC Wright P Van Damme H-J Schmitt A Meheus, Vaccine 2006 24 Suppl 3 S178 86 16950005
4. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. DM Harper EL Franco C Wheeler D Ferris D Jenkins A Schuind T Zahaf B Innis P Naud N De Carvalho, Lancet 2004 364 1757 65 10.1016/S0140- 6736(04)17398-4 15541448
5. Provisional recommendations for the use of the quadrivalent HPV vaccine. Advisory Committee on Immunization Practices, Centers for Disease Control, Atlanta http://www.cdc.gov/nip/recs/provisional_recs/hpv.pdf August 14, 2006
6. Prophylactic HPV vaccines: underlying mechanisms. M Stanley DR Lowy I Frazer, Vaccine 2006 24 Suppl 3 106 13 10.1016/j.vaccine.2006.05.110
7. Modelling the impact of HPV vaccines on cervical cancer and screening programmes. GP Garnett JJ Kim K French SJ Goldie, Vaccine 2006 24 Suppl 3 S178 86 10.1016/j.vaccine.2006.05.116 16950005
8. Psychosocial aspects of vaccine acceptability. GD Zimet N Liddon SL Rosenthal E Lazcano-Ponce B Allen, Vaccine 2006 24 Suppl 3 S201 209 10.1016/j.vaccine.2006.06.017 16950008
9. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. L Brabin SA Roberts F Farzaneh HC Kitchener, Vaccine 2006 24 3087 94 10.1016/j.vaccine.2006.01.048 16500736
10. Sexual behaviour in Britain: early heterosexual experience. K Wellings K Nanchahal W Macdowall S McManus B Erens CH Mercer A Johnson, Lancet 2001 357 1843 50 10.1016/S0140-6736(01)06885-4
11. Informed consent: is it sacrosanct? A Assiter, Research Ethics Rev 2005 1 77 83
12. Autonomy and adolescence: a concept analysis. HJ Spear P Kulbok, Public Health Nursing 2004 21 144 52 10.1111/j.0737-1209.2004.021208.x 14987214
13. Principles of Biomedical Ethics. T Beauchamp J Childress, New York: Oxford University Press 5 2001
14. Laws and Policies Affecting Adolescent Health. JM Paxman R Zuckerman, World Health Organisation, Geneva 1987
15. Gillick vs West Norfolk & Wisebech Area Health Authority & the DHSS [1985]. ALL ERR 402 (HL)
16. Best practice guidance for doctors and other health professionals on the provision of advice and treatment to young people under 16 on contraception, sexual and reproductive health. UK Department of Health, London 2004
17. Confidential reproductive health services for minors: the potential impact of mandated involvement for contraception. RK Jones H Boonstra, Persp Sex Reprod Hlth 2004 36 182 91
18. "Any other comments?" Open questions on questionnaires - a bane or a bonus to research? A O'Cathain KJ Thomas, BMC Medical Research Methodology 2004 4 25 15533249 10.1186/1471-2288-4-25
19. Sexual health in Britain. Recent changes in high-risk sexual behaviours and the epidemiology of sexually transmitted infections including HIV. Public Health Laboratory Service Communicable Disease Surveillance Centre, London 2002
20. HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. HC Kitchener M Almonte P Wheeler M Desai C Gilham A Bailey A Sargent J Peto on behalf of the ARTISTIC Trial Study Group, B J Cancer 2006 95 56 61 10.1038/sj.bjc.6603210
21. Biological and hormonal markers of chlamydia, human papillomavirus, and bacterial vaginosis among adolescents attending genitourinary medicine clinics. L Brabin E Fairbrother D Mandal SA Roberts SP Higgins S Chandiok P Wood G Barnard HC Kitchener, Sex Trans Infect 2005 81 128 32 10.1136/sti.2004.010223
22. The National Strategy for Sexual Health and HIV. Implementation Action Plan. UK Department of Health, London 2002
23. Greater use of pharmacies to access the "morning after pill". National Statistics: News Release, http://www.statistics.gov.uk/pdfdir/map1005. pdf 28 October 2005
24. Adolescents' reports of parental knowledge of adolescents' use of sexual health services and their reactions to mandated parental notification for prescription contraception. RK Jones A Purcell S Singh LB Finer, JAMA 2005 292 340 8 10.1001/jama.293.3.340
25. Parental notification laws for minors' access to contraception. What do parents say? ME Eisenberg C Swain LH Bearinger RE Sieving MD Resnick, Arch Pediatr Adolesc Med 2005 159 120 25 10.1001/archpedi.159.2.120 15699304
26. Intersections of gender and age in health care: adapting autonomy and confidentiality for the adolescent girl. KC Pinto, Qualitative Health Research 2004 14 78 99 10.1177/1049732303259674 14725177
27. Longitudinal development of family decision making: defining health behavioural autonomy for middle-class American adolescents. JG Smetana N Campione-Barr C Daddis, Child Development 2004 75 1418 34 10.1111/j.1467-8624. 2004.00749.x 15369523
28. The influence of primary caregivers on the sexual behaviour of early adolescents. A Rose HP Koo B Bhaskar K Anderson G White RR Jenkins, J Adolesc Health 2005 37 135 44 10.1016/j.jadohealth.2005.02.009 16026723
29. Does parental involvement predict new sexually transmitted diseases in female adolescents? JA Bettinger DD Celentano FC Curriero NE Adler SG Millstein JM Ellen, Arch Pediatr Adolesc Med 2004 158 666 70 10.1001/archpedi.158.7.666 15237066
30. Determinants of universal adolescent hepatitis B vaccine uptake. LA Wallace JC Bramley S Ahmed R Duff SJ Hutchinson WF Carman NRE Kitchin DJ Goldberg, Arch Dis Child 2004 89 1041 42 10.1136/adc.2003.043687 15499061
31. Informed consent law, ethics, and practice: from infancy to reflective adolescence. R Berry, HEC Forum 2005 17 64 8 10.1007/s10730-005-4951-7 15957269
32. ABC of adolescence. Consent, competence, and confidentiality. V Larcher, BMJ 2005 330 353 6 15705696 10.1136/bmj.330.7487.353
33. Sexually transmitted infections in the UK: New episodes seen at genitourinary medicine clinics, 1991-2001. PHLS, DHSSP&S and the Scottish ISD(D)5 Collaborative Group, London 2002
34. Changing parental opinions about teen privacy through education. JW Hutchinson EM Stafford, Peds 2005 116 966 71 10.1542/peds.2005-0318
35. The influence of parental monitoring on adolescent sexual initiation. JA Sievarding N Adler S Witt J Ellen, Arch Pediatr Adolesc Med 2005 159 724 9 10.1001/archpedi.159.8.724 16061779
36. Recommending STI vaccination to parents of adolescents: the attitudes of nurse practitioners. RM Mays GD Zimet, STD 2004 31 428 32 10.1097/01.OLQ. 0000130536.71812.E5